Abstract
This review focuses on the biological role and clinical relevance of relatively poor studied enzymes known as sialidases. We describe structure and function of sialic acid, in particular as a component of gangliosides and plasma lipoproteins. Several types of sialidases are known in mammals, of which trans-sialidase is of special interest, since it is capable of removing sialic acid from low density lipoprotein (LDL) particles and transferring it to different acceptors in blood plasma. Desialylation of LDL, in turn, endows it a capacity to accumulate in the smooth muscle cells of human aortic intima, and therefore is important for atherogenesis. Moreover, sialidases appear to be involved in a variety of pathological processes, including viral infections and cancer, which makes these enzymes an attractive therapeutic target.
Keywords: Sialidase, trans-sialidase, desialylation, sialic acid, atherosclerosis, LDL.
Current Pharmaceutical Design
Title:Sialidases: Therapeutic and Antiatherogenic Potential
Volume: 23 Issue: 31
Author(s): Vasily Nikolaevich Sukhorukov *, Vasily Petrovich Karagodin , Emile Rustemovich Zakiev , Andrey Vyacheslavovich Grechko and Alexandr Nikolaevich Orekhov
Affiliation:
- Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow,Russian Federation
Keywords: Sialidase, trans-sialidase, desialylation, sialic acid, atherosclerosis, LDL.
Abstract: This review focuses on the biological role and clinical relevance of relatively poor studied enzymes known as sialidases. We describe structure and function of sialic acid, in particular as a component of gangliosides and plasma lipoproteins. Several types of sialidases are known in mammals, of which trans-sialidase is of special interest, since it is capable of removing sialic acid from low density lipoprotein (LDL) particles and transferring it to different acceptors in blood plasma. Desialylation of LDL, in turn, endows it a capacity to accumulate in the smooth muscle cells of human aortic intima, and therefore is important for atherogenesis. Moreover, sialidases appear to be involved in a variety of pathological processes, including viral infections and cancer, which makes these enzymes an attractive therapeutic target.
Export Options
About this article
Cite this article as:
Sukhorukov Nikolaevich Vasily*, Karagodin Petrovich Vasily, Zakiev Rustemovich Emile, Grechko Vyacheslavovich Andrey and Orekhov Nikolaevich Alexandr , Sialidases: Therapeutic and Antiatherogenic Potential, Current Pharmaceutical Design 2017; 23 (31) . https://dx.doi.org/10.2174/1381612823666170609082324
DOI https://dx.doi.org/10.2174/1381612823666170609082324 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nitric Oxide in Cancer Therapeutics: Interaction with Cytotoxic Chemotherapy
Current Pharmaceutical Design The Road to Device Miniaturization in Echocardiography
Recent Patents on Medical Imaging Modeling Cardiovascular Development: New Approaches are Making In Vitro En Vogue
Current Cardiology Reviews Orthotopic Heart Transplantation in Patients with Univentricular Physiology
Current Cardiology Reviews Treatment of Cardiovascular Risk Factors in Women
Current Medicinal Chemistry Impact of Postprandial Remnant Lipoproteins on Coronary Artery Disease
Vascular Disease Prevention (Discontinued) Role of microRNAs in Vascular Remodeling
Current Molecular Medicine Vascular Progenitor Cells in the Development of Transplant Arteriopathy
Current Genomics CPR Technique for Infants and Children
Current Pediatric Reviews Endothelial Dysfunction, Obesity and Insulin Resistance
Current Vascular Pharmacology Proteomics Analysis Revealed an Altered Left Ventricle Protein Profile in a Mouse Model of Transverse Aortic Constriction
Protein & Peptide Letters High Sensitivity Troponin in Cardiovascular Disease. Is There More Than a Marker of Myocardial Death?
Current Topics in Medicinal Chemistry Calcific Aortic Valve Disease and Hypertension
Current Hypertension Reviews Emblica officinalis (Amla) Ameliorates High-Fat Diet Induced Alteration of Cardiovascular Pathophysiology
Cardiovascular & Hematological Agents in Medicinal Chemistry New Perspectives on Acetaminophen
Current Cardiology Reviews Acute Cardioembolic Cerebral Infarction: Answers to Clinical Questions
Current Cardiology Reviews Inflammatory Mediators and the Failing Heart: A Translational Approach
Current Molecular Medicine Ubiquitin and ubiquitin-like proteins in cardiac disease and protection
Current Drug Targets The Heme Oxygenase System and Type-1 Diabetes
Current Pharmaceutical Design The Hypothalamic-Neurohypophyseal System: Current and Future Treatment of Vasopressin and Oxytocyn Related Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)